AUTISM EVALUATIONS

How EarliPoint™ Works

EarliPoint™ is the first biomarker-based, eye-tracking diagnostic technology specifically designed to aid in the diagnosis and assessment of autism in young children. This revolutionary tool is authorized for use in children between 16 and 30 months of age, providing clinicians with objective and reliable measurements of each child’s strengths and vulnerabilities.

The EarliPoint™ evaluation tool measures children’s looking behavior, tracking their eye movements to gather critical data. This data is then used to produce objective measurements that can predict expert clinician assessments with a high degree of accuracy. These measurements offer valuable insights into a child’s developmental progress, helping to identify signs of autism at an earlier stage than traditional methods.

Benefits of Early Diagnosis with EarliPoint™

• Objective Measurements: EarliPoint™ provides clinicians with clear, data-driven insights into a child’s development, enabling more accurate diagnoses.

• Speedy Diagnoses: By offering objective measurements, EarliPoint™ can significantly reduce the time it takes to diagnose autism, allowing for earlier intervention.

• Early Intervention Leads to Better Outcomes:

  Research shows that early diagnosis and intervention are crucial for children with autism. Starting treatment at a younger age can lead to improved outcomes in communication, social skills, and overall development.

• Cost-Effective Care: Early intervention not only benefits the child but can also reduce the lifetime costs associated with autism for families and society. By identifying and addressing autism early, families can access the support and resources needed to help their children thrive.